This panel will explore:

• Biggest challenges for Quality Management at this time
• Is it possible to still push for quality improvement in a time like this?
• The effect of COVID-19 on the Sustainable Development Goals
• Maintaining quality and patient safety in resource restricted environments
• How to ensure staff motivation and safety?
• The role of innovation and telemedicine of COVID : What have we learnt and thoughts for the future?
• What does the future of quality in healthcare look like?

Session Chair

Dr Samer Ellahham, Regional Chair, Middle East, Patient Safety Movement Foundation, Cleveland Clinic Caregiver, Senior Cardiovascular Consultant, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Speaker/ Panelists

• Jacqui Stewart, Chief Executive Officer, The Council for Health Service Accreditation of Southern Africa NPC, Cape Town, South Africa
• Dr Rola Hammoud, Chief Medical Officer, Clemenceau Medical Centre, Dubai, UAE, President, Lebanese Society for Quality and Safety in Healthcare, Beirut, Lebanon
• Dr Jimi Coker, Board Member and Chairman, Technical Committee, Society for Quality in Healthcare in Nigeria (SQHN), Lagos, Nigeria
• Dr Karen Luxford, CEO, The Australian Council on Healthcare Standards and ACHS International, New South Wales, Australia

Reviewing how COVID-19 has impacted surgical procedures, considering ward admission, anesthesia, surgery and recovery.

Session Chair

• Dr Ammar Salti, Consultant, Anesthesia & Pain Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
• Dr Arun Kumar, Consultant Cardiothoracic Anaesthesiologist & Clinical Associate Professor in Anaesthesiology, Cleveland Clinic Lerner College of Medicine, Medical Director, Transplant Anaesthesiology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Speaker/ Panelists

• Dr Paul Barach, Clinical Professor, Wayne State University School of Medicine, Children’s Hospital of Michigan, Patient Safety Committee Member, American Society of Anesthesiologists, Detroit, Michigan, USA

MSCs, convalescent serum, PRP are currently being used to treat conditions outside of the normal milieu of what is generally accepted. Clinical scientists will have a conversation around how this shift will impact Musculoskeletal regenerative medicine.

Session Chair

Dr William Murrell, President and Founder, the American Academy Board of Regenerative Medicine – Middle East North Africa, Consultant Orthopaedic Surgeon, Healthpoint, Dubai, UAE

Speaker/ Panelists

• Dr Brian J. Cole, Associate Chairman and Professor, Department of Orthopaedics, Chairman, Department of Surgery, Rush OPH, Team Physician, Chicago Bulls, Chicago White Sox and Chicago Dogs, Rush University Medical Center, Chicago, Illinois, USA
• Dr Elizaveta Kon, Associate Professor, Humanitas University, Orthopaedic Surgeon, Joint Reconstruction Center, Humanitas Research Hospital, Milan, Italy
• Dr Kirill Micallef Stafrace, Consultant Sports and Exercise Medicine, Medical Director, Malta Football Association; Chairman, Medical Commission of the Maltese Olympic Committee; Senior Lecturer, University of Malta, Msida, Malta
• Prof Dr Nicola Maffulli, Consultant Orthopaedic and Sports Injury Surgeon, Professor of Sport Medicine, Barts and The London School of Medicine and Dentistry, Director of The Centre for Sport and Exercise Medicine, London, UK
• Dr Allan Mishra, Orthopaedist, Sports Medicine Surgeon, Menlo Medical Clinic, Stanford Healthcare, Palo Alto, California, USA